News

QuickLogic's Q3 2024 Financial Results: Key Insights and Analysis

QuickLogic's Q3 2024 Financial Results: Key Insights and Analysis

QuickLogic Corporation Financial Results Overview

QuickLogic Corporation (NASDAQ: QUIK), a leading innovator in embedded FPGA solutions, has recently disclosed its financial outcomes for the fiscal third quarter culminating on September 29, 2024. The company is renowned for its cutting-edge embedded FPGA (eFPGA) technologies, ruggedized FPGAs, and AI-driven solutions. This update provides an insightful view into its recent performance and strategic directions.

Highlights from Recent Results

In the latest quarter, QuickLogic reported several noteworthy achievements that reflect its ongoing commitment to innovation and market leadership. Here are some of the critical highlights:

Operational Milestones

  • Q3 results aligned well with previous guidance.
  • Progress on the Strategic Radiation Hardened FPGA Technology contract with the U.S. Government continues to advance through its third tranche.
  • Successful delivery of eFPGA IP for GlobalFoundries' 12LP process to a substantial defense sector client.
  • A record turnaround was achieved in delivering eFPGA IP for TSMC's N12e 12nm process to a major multinational customer—a feat accomplished in just three months.
  • Development of an eFPGA Hard IP core is ongoing, expected to be the first for Intel's 18A process, with initial delivery targeted for the end of 2024.
  • SensiML's collaboration with eFabless aims to facilitate open-source Edge AI innovation.
  • The SensiML platform has now expanded to support RISC-V architecture.
  • An agreement was struck with Synopsys to incorporate Synopsys Synplify in the Aurora FPGA User Tool Suite.

Financial Performance Analysis

The fiscal Q3 of 2024 concluded with total revenue reaching $4.3 million. This figure marks a decline of 35.9% compared to the same period in 2023 but reflects a 3.5% growth over the previous quarter.

Breakdown of Revenue Sources

New product revenue during this quarter was about $3.5 million. This represents a drop of 42.0% year-over-year, primarily due to the timing discrepancies in deliverables for important eFPGA IP contracts. Conversely, there was a 15.7% increase in new product revenue compared to Q2 2024.

Mature product revenue increased slightly to $0.7 million from $0.6 million a year prior, with a decrease from $1.1 million in Q2 2024.

Margin Insights

The GAAP gross margin for Q3 2024 stood at 55.8%, showing a decrease from 76.9% in Q3 2023, but an improvement over the 51.0% seen in Q2 2024. Non-GAAP gross margin for the same period was recorded at 60%, down from 78% year-on-year, yet up from 53.1% in the prior quarter.

Operating expenses for the quarter were $4.2 million, an increase from the $3.8 million reported in Q3 2023 and $3.6 million in Q2 2024. Non-GAAP operating expenses remained steady at $3.3 million, with a year's comparison also reflecting no changes.

In terms of net loss, QuickLogic reported a GAAP net loss of $2.1 million, which translates to $(0.14) per share, contrasting against net income of $1.2 million, or $0.09 per share in Q3 2023, as well as a loss of $(0.11) in the last quarter. Non-GAAP results indicated a net loss of $0.9 million, or $(0.06) per share, compared to a gain of $1.8 million or $0.13 per share from last year’s third quarter.

Webcast and Future Directions

To provide further clarity on the financial outcomes and future strategies, QuickLogic will host a conference call. This session will offer insights into ongoing initiatives and responses to stakeholder inquiries. QuickLogic’s focus remains on delivering innovative solutions and optimizing operational efficiencies.

About QuickLogic Corporation

QuickLogic is a fabless semiconductor organization that crafts advanced embedded FPGA IP, discrete FPGAs, and FPGA SoCs tailored for diverse applications across various sectors including industrial, aerospace, and consumer electronics. With its subsidiary, SensiML Corporation, the company enhances its offering by providing AI/ML software solutions that enable edge/endpoint AI acceleration.

Frequently Asked Questions

What was QuickLogic's total revenue for Q3 2024?

QuickLogic reported total revenue of $4.3 million for Q3 2024.

How does the Q3 2024 revenue compare to Q3 2023?

Q3 2024 revenue represents a 35.9% decline compared to Q3 2023.

What strategic partnerships did QuickLogic engage in?

QuickLogic partnered with companies like eFabless for AI innovation and Synopsys for tool integration.

What was the GAAP gross margin for Q3 2024?

The GAAP gross margin for Q3 2024 was 55.8%.

What areas of technology does QuickLogic focus on?

QuickLogic specializes in embedded FPGA technologies and the development of solutions for AI applications in various industries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Recent Dealings of Apax Global Alpha Limited

Updated Category News Views 210

Overview of Dealings Apax Global Alpha Limited recently announced dealings that have significant implications for investors. This overview explores the key information surrounding their transactions, which can shed light on future strategies and market movements. It is essential for stakeholders to stay informed about these developments to make strategic investment...

Continue Reading
QuickLogic's Q3 2024 Financial Results: Key Insights and Analysis

Updated Category News Views 199

QuickLogic Corporation Financial Results Overview QuickLogic Corporation (NASDAQ: QUIK), a leading innovator in embedded FPGA solutions, has recently disclosed its financial outcomes for the fiscal third quarter culminating on September 29, 2024. The company is renowned for its cutting-edge embedded FPGA (eFPGA) technologies, ruggedized FPGAs, and AI-driven solutions....

Continue Reading
Advancements in Quantum Computing: A Milestone for QuEra

Updated Category News Views 158

Revolutionizing Quantum Computing with Magic State Distillation Landmark experiment delivers a key building block for universal, fault-tolerant quantum computing A collaborative research team from QuEra Computing, Harvard University, and MIT has made remarkable strides in quantum computing. The researchers have successfully executed the first experimental demonstration of...

Continue Reading
Sterling Infrastructure: Keeping an Eye on Earnings Ahead

Updated Category News Views 187

Sterling Infrastructure’s Earnings – A Must-Watch Event There's a bit of buzz around Sterling Infrastructure (NASDAQ:STRL) as the quarterly earnings release is almost upon us—mark it down for February 25, 2026. Now, for the rookies in the game, I gotta stress that earnings day isn’t just about the numbers coming in. Sure, analysts are gabbing about an expected...

Continue Reading
Exploring the Future of Brain-Computer Interfaces Market Growth

Updated Category News Views 209

Understanding Brain-Computer Interfaces (BCI) Brain-computer interfaces (BCIs) represent a remarkable technological advancement that translates neural signals into actionable commands for various devices. These systems are opening doors for individuals with disabilities, especially those experiencing severe motor impairments like paralysis. Researchers are delving deep...

Continue Reading